TeleSpecialists Unveils AI-Powered Registry to Revolutionize Stroke Care

NEW ORLEANS, LA – February 04, 2026 – In a move poised to reshape the landscape of stroke treatment, TeleSpecialists today launched its TeleStroke Registry™ and The Collective at the International Stroke Conference. The physician-led teleneurology practice introduced what it calls a new category of “stroke care intelligence,” a data-driven platform designed to arm hospitals with the analytics needed to elevate their stroke programs.

The platform is built on a massive foundation of real-world data, comprising more than 450,000 telestroke patient encounters and 90 million distinct clinical and operational data points. It aims to translate this vast repository of information into actionable intelligence, helping hospital leaders strengthen accreditation readiness, benchmark performance against national norms, and refine operations without the burden of creating and maintaining an internal database.

“Unlike traditional reporting tools or passive data repositories, the TeleStroke Registry functions as a stroke care intelligence platform and benchmarking engine for real programs, giving hospitals visibility into how they perform relative to peer institutions, similar acuity programs, and national telestroke norms,” said Registry Co-Chair, Theresa Sevilis, DO, FAAN, in the company’s announcement.

A New Frontier in Stroke Intelligence

While TeleSpecialists bills its platform as a “new category,” it represents a powerful integration of several rapidly advancing trends in healthcare: big data analytics, artificial intelligence, and telehealth. The telestroke services market is already on a steep growth trajectory, projected to exceed $6.9 billion by 2035, fueled by a shortage of on-site neurologists and the need for rapid expert consultation.

Simultaneously, AI has been making significant inroads into stroke care, with companies like Viz.ai and Brainomix developing tools that use algorithms to analyze medical images and speed up diagnostic workflows. TeleSpecialists’ offering carves out a distinct niche by focusing not just on individual patient diagnostics, but on the programmatic health of an entire stroke service line. It analyzes patterns across hundreds of thousands of cases to provide insights into operational efficiency, quality metrics, and market positioning.

“Hospitals don’t need more data—they need clarity,” Dr. Sevilis stated. “The Registry allows stroke leaders to walk into accreditation surveys, leadership meetings, and quality reviews with clear evidence of how their program performs, where variation exists, and exactly what impacts patient care.” This shift from raw data to curated intelligence is what the company believes will set its platform apart in a crowded health-tech field.

The Accreditation and Quality Advantage

For hospital administrators, a primary value proposition of the new registry lies in its potential to streamline the complex and high-stakes process of stroke center accreditation. Certifying bodies like The Joint Commission and the American Heart Association/American Stroke Association (AHA/ASA) require hospitals to meticulously track and report on performance measures, from door-to-needle times for clot-busting drugs to patient outcomes.

The TeleStroke Registry™ is designed to directly support these requirements. By providing continuous, real-time benchmarking against peer facilities and national telestroke data, it gives quality improvement managers a powerful tool to identify areas for improvement and demonstrate compliance. Instead of relying on manually compiled internal data, which can be resource-intensive and lack external context, hospitals can now access a dynamic, evidence-based view of their performance.

This data-driven approach is crucial for maintaining certification as a Primary, Thrombectomy-Capable, or Comprehensive Stroke Center. The ability to pinpoint operational bottlenecks or variations in care and then implement targeted improvements is at the core of modern quality assurance. The platform promises to equip hospitals with the precise evidence needed to not only pass accreditation surveys but also to build and defend a reputation for excellence in a competitive healthcare market.

Fostering Collaborative Research with 'The Collective'

Beyond individual hospital performance, TeleSpecialists is aiming to advance stroke science on a larger scale with The Collective, a research-focused subset of the registry. This initiative creates a collaborative framework for multi-site research, allowing partner hospitals to contribute to and benefit from a massive, aggregated dataset without needing to build their own costly research infrastructure.

“What makes this powerful from a research perspective is the scale and the real-world nature of the data,” explained Amanda Avila, MD, Registry Co-chair. “Hospitals can contribute to advancing stroke science and quality benchmarks in a way that is practical and directly connected to how care is actually delivered.”

This approach leverages the power of real-world evidence (RWE), which is increasingly valued for its ability to reflect the complexities and diversity of actual patient populations, in contrast to the highly controlled and often narrow conditions of traditional clinical trials. By pooling anonymized data from numerous institutions, The Collective can help researchers identify trends, validate new treatment protocols, and establish best practices that are applicable across a wide range of community and health system settings.

To spur adoption, TeleSpecialists is offering complimentary access to the first 100 partner hospitals and health systems that join The Collective, providing an immediate incentive for facilities to become part of this burgeoning research network.

Navigating the Path to Adoption

Despite the platform’s promising features, its widespread adoption will depend on overcoming several key challenges common to new healthcare technologies. Seamless integration with the myriad of Electronic Medical Record (EMR) systems used by hospitals is a significant technical hurdle. Without smooth data interoperability, the platform's utility could be hampered.

Furthermore, the long-term cost will be a critical factor for hospital executives. While the initial offer for The Collective is complimentary, the ultimate pricing structure for the registry will need to demonstrate a clear return on investment, whether through improved operational efficiency, enhanced revenue from a high-performing stroke program, or reduced costs associated with accreditation compliance. Staff training and adapting clinical workflows to incorporate the new intelligence will also require institutional commitment.

However, powerful market forces are working in the platform’s favor. The growing demand for data-driven decision-making, coupled with the persistent shortage of neurological specialists that drives the telestroke market, creates a fertile environment for such an innovation. As healthcare continues its inexorable shift toward digital solutions and value-based care, tools that provide clarity and evidence of performance are no longer a luxury, but a necessity for survival and success.